Lichenoid Drug Eruption with Palmoplantar Hyperkeratosis due to Imatinib Mesylate: A Case Report and a Review of the Literature

Authors

  • Natsuki Kuraishi
  • Yayoi Nagai
  • Michiko Hasegawa
  • Osamu Ishikawa

DOI:

https://doi.org/10.2340/00015555-0758

Keywords:

lichenoid drug eruption, palmoplantar hyperkeratosis, imatinib mesylate

Abstract

Cutaneous adverse effects of imatinib mesylate (Glivec) are common and various types of skin eruptions have been reported. We report here a 57-year-old man who presented with lichen planus-like lesions on his extremities and palmoplantar hyperkeratosis due to the use of imatinib mesylate for chronic myeloid leukaemia. The skin lesions improved after discontinuation of imatinib mesylate but re-administration of the drug at a lower dose provoked a mild recurrence. He could, however, continue to take the drug at the lower dose and his skin lesions were well-controlled by topical corticosteroid treatment. The literature on lichenoid drug eruption due to imatinib mesylate is reviewed.

Downloads

Download data is not yet available.

Downloads

Published

2009-12-03

How to Cite

Kuraishi, N., Nagai, Y., Hasegawa, M., & Ishikawa, O. (2009). Lichenoid Drug Eruption with Palmoplantar Hyperkeratosis due to Imatinib Mesylate: A Case Report and a Review of the Literature. Acta Dermato-Venereologica, 90(1), 73–76. https://doi.org/10.2340/00015555-0758

Issue

Section

Articles